The role of insulin-like growth factor 1 and its receptor in the formation and development of colorectal carcinoma

Journal of International Medical Research

Volumn 41, Issue 4, 2013, Pages 1228-1235

  Zhang, Rong ^a   Xu, Guo Liang ^a   Li, Yin ^a   He, Long Jun ^a   Chen, Li Ming ^a   Wang, Guo Bao ^a   Lin, Shi Yong ^a   Luo, Guang Yu ^a   Gao, Xiao Yan ^a   Shan, Hong Bo ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

colorectal carcinoma; colorectal polyps; enzyme linked immunosorbent assay; Insulin like growth factor 1; insulin like growth factor receptor; quantitative real time RT PCR

Indexed keywords

SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; COLONOSCOPY; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; POLYPECTOMY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE LEVEL;

EID: 84887338326     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513487631     Document Type: Article

References (41)

1. Gupta S.Colorectal polyps: the scope and management of the problem.Am J Med Sci. 2008;336:407-417.
2. Jass JR,Young J,Leggett BA.Evolution of colorectal cancer: change of pace and change of direction.J Gastroenterol Hepatol. 2002;17:17-26.
3. Ahlquist DA.Molecular detection of colorectal neoplasia.Gastroenterology. 2010;138:2127-2139.
4. Kucera R,Cerna M,Narsanska A,et al.Growth factors and breast tumors, comparison of selected growth factors with traditional tumor markers.Anticancer Res. 2011;31:4653-4656.
5. McCarty G,Awad O,Loeb DM.WT1 protein directly regulates expression of vascular endothelial growth factor and is a mediator of tumor response to hypoxia.J Biol Chem. 2011;286:43634-43643.
6. Kasprzak A,Adamek A.The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (review).Int J Oncol. 2012;41:1919-1931.
7. Rapisarda A,Melillo G.Role of the VEGF/VEGFR axis in cancer biology and therapy.Adv Cancer Res. 2012;114:237-267.
8. Ozkan EE.Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.Mol Cell Endocrinol. 2011;344:1-24.
9. Dupont J,Pierre A,Froment P,et al.The insulin-like growth factor axis in cell cycle progression.Horm Metab Res. 2003;35:740-750.
10. Woelfle J,Billiard J,Rotwein P.Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b.J Biol Chem. 2003;278:22696-22702.
11. Chesik D,Glazenburg K,Wilczak N,et al.Insulin-like growth factor binding protein-1-6 expression in activated microglia.Neuroreport. 2004;15:1033-1037.
12. Duan C.The chemotactic and mitogenic responses of vascular smooth muscle cells to insulin-like growth factor-I require the activation of ERK1/2.Mol Cell Endocrinol. 2003;206:75-83.
13. Kim B,van Golen CM,Feldman EL.Insulin-like growth factor-I signaling in human neuroblastoma cells.Oncogene. 2004;23:130-141.
14. Ikeo S,Yamauchi K,Shigematsu S,et al.Differential effects of growth hormone and insulin-like growth factor I on human endothelial cell migration.Am J Physiol Cell Physiol. 2001;280:C1255-1261.
15. Qiang YW,Kopantzev E,Rudikoff S.Insulinlike growth factor-I signaling in multiple myeloma: downstream elements, functional correlates, and pathway cross-talk.Blood. 2002;99:4138-4146.
16. Del Valle L,Enam S,Lassak A,et al.Insulin-like growth factor I receptor activity in human medulloblastomas.Clin Cancer Res. 2002;8:1822-1830.
17. Saikali Z,Setya H,Singh G,et al.Role of IGF-1/IGF-1R in regulation of invasion in DU145 prostate cancer cells.Cancer Cell Int. 2008;8:10-10.
18. Ibrahim YH,Yee D.Insulin-like growth factor-I and cancer risk.Growth Horm IGF Res. 2004;14:261-269.
19. Hartog H,Wesseling J,Boezen HM,et al.The insulin-like growth factor 1 receptor in cancer: old focus, new future.Eur J Cancer. 2007;43:1895-1904.
20. Wu Y,Yakar S,Zhao L,et al.Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.Cancer Res. 2002;62:1030-1035.
21. Fukuda R,Hirota K,Fan F,et al.Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells.J Biol Chem. 2002;277:38205-38211.
22. Weber MM,Fottner C,Liu SB,et al.Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.Cancer. 2002;95:2086-2095.
23. Ouban A,Muraca P,Yeatman T,et al.Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas.Hum Pathol. 2003;34:803-808.
24. Remacle-Bonnet MM,Garrouste FL,Heller S,et al.Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.Cancer Res. 2000;60:2007-2017.
25. Natalishvili N,Axelson M,Girnita L,et al.Aberrant intracellular IGF-1R beta-subunit makes receptor knockout cells (IGF1R-/-) susceptible to oncogenic transformation.Exp Cell Res. 2009;315:1458-1467.
26. Vrieling A,Voskuil DW,Bosma A,et al.Expression of insulin-like growth factor system components in colorectal tissue and its relation with serum IGF levels.Growth Horm IGF Res. 2009;19:126-135.
27. Hakam A,Yeatman TJ,Lu L,et al.Expression of insulin-like growth factor-1 receptor in human colorectal cancer.Hum Pathol. 1999;30:1128-1133.
28. Nosho K,Yamamoto H,Taniguchi H,et al.Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.Clin Cancer Res. 2004;10:7950-7957.
29. Chao A,Thun MJ,Connell CJ,et al.Meat consumption and risk of colorectal cancer.JAMA. 2005;293:172-182.
30. Cooper HS.Pathologic issues in the treatment of endoscopically removed malignant colorectal polyps.J Natl Compr Canc Netw. 2007;5:991-996.
31. Chomczynski P,Sacchi N.Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.Anal Biochem. 1987;162:156-159.
32. Khatib AM,Siegfried G,Prat A,et al.Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions.J Biol Chem. 2001;276:30686-30693.
33. Jenkins PJ,Khalaf S,Ogunkolade W,et al.Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.Endocr Relat Cancer. 2005;12:891-901.
34. Best BP.Nuclear DNA damage as a direct cause of aging.Rejuvenation Res. 2009;12:199-208.
35. Maslov AY,Vijg J.Genome instability, cancer and aging.Biochim Biophys Acta. 2009;1790:963-969.
36. Rupnarain C,Dlamini Z,Naicker S,et al.Colon cancer: genomics and apoptotic events.Biol Chem. 2004;385:449-464.
37. Shan HB,Zhang R,Li Y,et al.Expression of IGF-1R in colorectal polyps and its role in colorectal carcinogenesis.Technol Cancer Res Treat. 2011;10:381-389.
38. Bostedt KT,Schmid C,Ghirlanda-Keller C,et al.Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.Exp Cell Res. 2001;271:368-377.
39. Hopfner M,Sutter AP,Huether A,et al.Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer.World J Gastroenterol. 2006;12:5635-5643.
40. Cooper GS,Doug Kou T.Underuse of colorectal cancer screening in a cohort of Medicare beneficiaries.Cancer. 2008;112:293-299.
41. Baxter N,Rabeneck L.New findings about the risks and limitations of colonoscopy used in the early detection of colorectal cancer.Healthc Q. 2009;12:24-25.